1 Department of Pharmacy Practice Jyothishmati Institute of Pharmaceutical Sciences, Karimnagar, Telangana, India.
2 Department of Pharmaceutics, Jyothishmati Institute of Pharmaceutical Sciences, Karimnagar, Telangana, India.
World Journal of Biology Pharmacy and Health Sciences, 2025, 24(01), 070-075
Article DOI: 10.30574/wjbphs.2025.24.1.0784
Received on 26 August 2025; revised on 04 October 2025; accepted on 06 October 2025
Coronary artery disease remains a leading cause of illness and death worldwide, with cigarette smoking being a significant modifiable risk factor for its onset and progression. This review examines the pathophysiological mechanisms by which smoking contributes to CAD, including endothelial dysfunction, chronic inflammation, and increased blood clotting tendencies. Epidemiological data emphasize the substantial burden of CAD among smokers and the direct link between smoking intensity and disease severity. Additionally, the review explores the harmful components of cigarette smoke and their specific effects on cardiovascular health. The paper highlights smoking cessation as a key strategy for preventing and managing CAD, addressing both its benefits and the challenges associated with quitting. It discusses various pharmacological and non-pharmacological interventions, underscoring the need for targeted smoking cessation programs to reduce CAD risk and enhance cardiovascular health.
Smoking; Coronary Artery Disease; Lipid Levels
Preview Article PDF
Nahiya Fathima, Humera Sadaf, B. Shivaprasad, G. Akash, G. Narender Naik and K. Purnachander. The impact of cigarette smoking on coronary artery disease: A comprehensive review. World Journal of Biology Pharmacy and Health Sciences, 2025, 24(01), 070-075. Article DOI: https://doi.org/10.30574/wjbphs.2025.24.1.0784.